期刊文献+

成人流行性腮腺炎流行病学及临床分析 被引量:5

Analysis of epidemiological and clinical characteristics of adult mumps patients
原文传递
导出
摘要 目的分析沈阳地区97例住院成人流行性腮腺炎患者的流行病学及临床特征,以利于更好地防治成人流行性腮腺炎。方法回顾性分析沈阳市第六人民医院2009年1—6月收治的97例住院患者的临床资料。结果成人流行性腮腺炎患者以男性为主,占全部病例的77.32%;发病年龄主要为18—30岁,占全部病例的78.35%;沈阳周边地区及外来流动人口(主要为农村到城市务工者)发病率高,占全部病例的71.13%。所有病例均出现腮腺肿大,但程度相对较轻,并发症多见。结论加强流动人口的管理,对成人采取以疫苗接种为主的综合措施有利于控制流行性腮腺炎的流行。 Objective To analyze epidemiological and clinical characteristics of 97 adult mumps inpatients in Shenyang and to search methods of the disease prevention and treatment. Methods The clinical data of 97 adult mumps inpatients from January 2009 to June 2009 in the Sixth People' s Hospital of Shenyang were analyzed retrospectively. Results Most cases occurred on males, accounted for 77.32%. The major cases were at the age from 18 to 30, accounted for 78.35%. Patients from the countryside of Shenyang and floating population accounted for 71.13 %. All patients presented parotid swelling, but the symptoms were not severe. The complications were common. Conclusions It is favorable to control the mumps epidemic through strengthening the management of floating population and take the proper vaccination for adults.
作者 杨涛 吴兵
出处 《国际流行病学传染病学杂志》 CAS 2010年第1期39-41,共3页 International Journal of Epidemiology and Infectious Disease
关键词 流行性腮腺炎 成人 流行病学 临床特征 Mumps Adults Epidemiology Clinical characteristics
  • 相关文献

参考文献4

二级参考文献14

  • 1许青,徐爱强,宋立志,张丽,肖作奎,王常银,李漫时,王爱莲,李震.山东省实施儿童风疹疫苗免疫后风疹发病年龄变化趋势的分析[J].中华流行病学杂志,2005,26(11):861-863. 被引量:65
  • 2张敏,彭怡纯.260例流行性腮腺炎患者流行特征及临床分析[J].中华流行病学杂志,2006,27(2):173-173. 被引量:11
  • 3彭文伟.传染病学[M].第5版.北京:人民卫生出版社,2002:75.
  • 4迮文远.计划免疫学[M](第2版)[M].上海:上海科学技术文献出版社,2000.359-381.
  • 5卫生部.预防接种工作规范[S].2005.
  • 6WPR/WHO.Resolution for Measles Elimination,Hepatitis B Control and Poliomyelitis Eradication (WPR/RC56.R8)[S].2005.
  • 7WHO.Accelerated Control of Rubella and Prevention of Congenital Rubella Syndrome,WHO Region of the Americas[J].WER,2003,78(8):50-54.
  • 8WHO.Rubella Vaccines,WHO position paper[J].WER,2000,75:161-172.
  • 9WHO.Mumps Virus Vaccines,WHO Position Paper[J].WER,2001,76:346-355.
  • 10Pebody R G,Gay N J,Hesketh L M,et al.Immunogenicity of Second Dose Measles-mumps-rubella(MMR)Vaccine and Implications for Serosurveillance[J].Vaccine,2002,20:1134-1140.

共引文献61

同被引文献25

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部